Bioprocessing Equipment
•29 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (29)
%
| Company | Market Cap | Price |
|---|---|---|
|
Bioprocessing Equipment (e.g., single-use bioreactors) is a core Thermo Fisher offering for biopharma production.
|
$198.11B |
$524.80
-1.88%
|
|
Bioprocessing Equipment includes platforms like Xcellerex X-platform bioreactors used for cell culture and biologics manufacturing.
|
$144.89B |
$202.46
-1.20%
|
|
Bioprocessing Equipment reflects Ecolab's Life Sciences segment, which supports biotech manufacturing through advanced processing and purification capabilities.
|
$77.14B |
$272.08
-0.70%
|
|
BD's bioprocessing equipment supports upstream/downstream processing in biopharmaceutical production.
|
$53.47B |
$186.56
-1.50%
|
|
Bioprocessing equipment supports biotech manufacturing, aligning with CDMO capabilities.
|
$40.00B |
$140.11
-0.12%
|
|
Bioprocessing equipment used in biopharma production, including containment-focused solutions, is a direct product category.
|
$32.81B |
$81.32
-1.06%
|
|
ADM's fermentation-based BioSolutions technologies potentially align with bioprocessing equipment categories.
|
$29.23B |
$60.84
-0.69%
|
|
MTD provides bioprocessing equipment used in biopharma production, including upstream/downstream hardware.
|
$26.47B |
$1273.67
-2.72%
|
|
Organ manufacturing initiatives rely on Bioprocessing Equipment for manufacturing engineered organs and related platforms.
|
$19.85B |
$440.00
-1.27%
|
|
Bioprocessing Equipment corresponds to Harvest RC bioprocessing filtration hardware in Purification & Filtration.
|
$12.91B |
$74.29
-0.42%
|
|
Bioprocessing equipment used in biopharmaceutical production workflows.
|
$9.91B |
$84.06
+0.79%
|
|
Bioprocessing Equipment includes upstream/downstream process hardware and single-use fluid handling systems central to Avantor's Bioscience Production segment.
|
$9.13B |
$13.40
-1.83%
|
|
Bioprocessing equipment encompasses the upstream/downstream processing hardware that Repligen provides or enables.
|
$8.16B |
$145.24
-2.08%
|
|
Bio-Rad provides bioprocessing equipment for upstream/downstream biopharmaceutical manufacturing.
|
$8.10B |
$284.88
|
|
ATS manufactures Bioprocessing Equipment used in radiopharma and other biotech production.
|
$2.46B |
$25.39
-3.90%
|
|
Bioprocessing equipment related to sample storage/handling (e.g., automated stores, cryogenic systems) are major hardware offerings from Azenta.
|
$1.41B |
$30.73
-3.30%
|
|
BioLife's Cell Processing platform, biopreservation tools, and related automated processing equipment constitute core bioprocessing equipment sold to CGT developers.
|
$1.17B |
$25.51
+3.74%
|
|
UltraCAR-T manufacturing device and bioprocessing equipment relevance (UltraPorator) ties to Bioprocessing Equipment.
|
$959.34M |
$3.25
-3.85%
|
|
RDW's SpaceMD initiative and in-space biotech tools (PIL-BOX) map to Bioprocessing Equipment for space-based pharmaceutical development.
|
$673.71M |
$8.74
-8.19%
|
|
Bioprocessing Equipment encompasses hardware used in biopharmaceutical production, including Gyrolab systems and related platforms.
|
$385.97M |
$70.75
+3.12%
|
|
Cerus's INTERCEPT Blood System and IFC are bioprocessing/biopharma processing equipment used to inactivate pathogens in blood components, a core product line.
|
$305.86M |
$1.60
-4.76%
|
|
Core product line: Bioprocessing equipment (ExPERT platform and VLx/ATx/STx) used for cell therapy manufacturing.
|
$167.98M |
$1.66
+5.06%
|
|
Growth Direct is a bioprocessing equipment platform used to automate microbial quality control in biopharma manufacturing.
|
$167.56M |
$3.79
+7.37%
|
|
Nu Aire acquisition adds biological safety cabinets, CO2 incubators, and ultralow freezers, aligning KEQU with the Bioprocessing Equipment category.
|
$118.12M |
$41.53
-3.37%
|
|
Bioprocessing Equipment tag captures the life sciences equipment aspect tied to biopharmaceutical production.
|
$42.72M |
$36.01
|
|
CTS (Cellulose-to-Sugar) processing involves bioprocessing equipment; BIOF is developing and scaling CTS machines (pilot/commercial scale), a direct equipment/product line.
|
$26.22M |
$0.18
+1.56%
|
|
Biopharmaceutical production-related equipment used for decontamination processes; fits Bioprocessing Equipment.
|
$20.22M |
$1.01
+1.01%
|
|
BTX electroporation systems are bioprocessing equipment used in biopharmaceutical production.
|
$18.55M |
$0.42
-5.64%
|
|
Directly manufactures bioprocessing equipment used in biopharmaceutical production.
|
$9.24M |
$0.80
+5.81%
|
Loading industry metrics...
Loading comparison data...
